The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
The need for parenteral drug administration, improved bioavailability, and innovative therapeutic options—including those suited for home-based treatments—drives the demand for delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results